Cargando…
Critical Assessment of a Structure-Based Screening Campaign for IDO1 Inhibitors: Tips and Pitfalls
Over the last two decades, indoleamine 2,3-dioxygenase 1 (IDO1) has attracted wide interest as a key player in immune regulation, fostering the design and development of small molecule inhibitors to restore immune response in tumor immunity. In this framework, biochemical, structural, and pharmacolo...
Autores principales: | Mammoli, Andrea, Bianconi, Elisa, Ruta, Luana, Riccio, Alessandra, Bigiotti, Carlo, Souma, Maria, Carotti, Andrea, Rossini, Sofia, Suvieri, Chiara, Pallotta, Maria Teresa, Grohmann, Ursula, Camaioni, Emidio, Macchiarulo, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999677/ https://www.ncbi.nlm.nih.gov/pubmed/35409342 http://dx.doi.org/10.3390/ijms23073981 |
Ejemplares similares
-
Turning a Tumor Microenvironment Pitfall into Opportunity: Discovery of Benzamidoxime as PD-L1 Ligand with pH-Dependent Potency
por: Bianconi, Elisa, et al.
Publicado: (2023) -
One Key and Multiple Locks: Substrate Binding in Structures of Tryptophan Dioxygenases and Hydroxylases
por: Mammoli, Andrea, et al.
Publicado: (2021) -
Indoleamine 2,3‐dioxygenase 1 (IDO1): an up‐to‐date overview of an eclectic immunoregulatory enzyme
por: Pallotta, Maria Teresa, et al.
Publicado: (2021) -
The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma
por: Orecchini, E, et al.
Publicado: (2023) -
The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1
por: Panfili, Eleonora, et al.
Publicado: (2023)